Pages that link to "Q34879008"

The following pages link to Methylthioninium chloride reverses cognitive deficits induced by scopolamine: comparison with rivastigmine. (Q34879008):

Displaying 33 items.

• Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease (Q26739412) (← links)
• A review on mitochondrial restorative mechanism of antioxidants in Alzheimer's disease and other neurological conditions (Q26781560) (← links)
• Abnormal Cognition, Sleep, EEG and Brain Metabolism in a Novel Knock-In Alzheimer Mouse, PLB1 (Q27314013) (← links)
• Cannabinoid and cholinergic systems interact during performance of a short-term memory task in the rat. (Q30473996) (← links)
• WIN55,212-2 induced deficits in spatial learning are mediated by cholinergic hypofunction (Q30474576) (← links)
• Phenothiazine-mediated rescue of cognition in tau transgenic mice requires neuroprotection and reduced soluble tau burden (Q30497435) (← links)
• Preventive methylene blue treatment preserves cognition in mice expressing full-length pro-aggregant human Tau. (Q30649677) (← links)
• Alzheimer's disease: clinical trials and drug development (Q33349401) (← links)
• Potential therapeutic strategies for Alzheimer's disease targeting or beyond β-amyloid: insights from clinical trials (Q34014237) (← links)
• Cellular and molecular actions of Methylene Blue in the nervous system (Q34422385) (← links)
• Methylene blue modulates β-secretase, reverses cerebral amyloidosis, and improves cognition in transgenic mice (Q34430920) (← links)
• Effects of imperatorin on scopolamine-induced cognitive impairment and oxidative stress in mice (Q35075169) (← links)
• Effects of oxidized and reduced forms of methylthioninium in two transgenic mouse tauopathy models (Q35558517) (← links)
• Alzheimer's disease and the amyloid cascade hypothesis: a critical review (Q35855587) (← links)
• Protective effects of mangosteen extract on H2O2-induced cytotoxicity in SK-N-SH cells and scopolamine-induced memory impairment in mice (Q37416657) (← links)
• Risk of severe serotonin toxicity following co-administration of methylene blue and serotonin reuptake inhibitors: an update on a case report of post-operative delirium (Q37474062) (← links)
• Neurometabolic mechanisms for memory enhancement and neuroprotection of methylene blue. (Q37954003) (← links)
• Mitochondrial Dysfunction—A Pharmacological Target in Alzheimer's Disease (Q38007107) (← links)
• Tau-directed approaches for the treatment of Alzheimer's disease: focus on leuco-methylthioninium (Q38715233) (← links)
• Emerging amyloid and tau targeting treatments for Alzheimer's disease (Q39296311) (← links)
• Progress in the development of new drugs in Alzheimer's disease (Q39789745) (← links)
• Differential metformin dose-dependent effects on cognition in rats: role of Akt. (Q39823034) (← links)
• Evaluation of the effect of Cyperus rotundus L. in scopolamine-induced learning deficit in mice (Q41955251) (← links)
• Sazetidine-A, a selective α4β2 nicotinic acetylcholine receptor ligand: effects on dizocilpine and scopolamine-induced attentional impairments in female Sprague–Dawley rats (Q42754120) (← links)
• Spatial learning impairments in PLB1Triple knock-in Alzheimer mice are task-specific and age-dependent. (Q45924774) (← links)
• Anti-amnestic Effect of Curcumin in Combination with Donepezil, an Anticholinesterase Drug: Involvement of Cholinergic System (Q46436614) (← links)
• Effects of optimized-SopungSunkiwon on memory impairment and enhancement (Q47326879) (← links)
• An anti-nicotinic cognitive challenge model using mecamylamine in comparison with the anti-muscarinic cognitive challenge using scopolamine. (Q48219255) (← links)
• 5-HT6 receptor blockade differentially affects scopolamine-induced deficits of working memory, recognition memory and aversive learning in mice (Q50965059) (← links)
• Repurposing Proteostasis-Modifying Drugs to Prevent or Treat Age-Related Dementia: A Systematic Review (Q58697971) (← links)
• Mechanisms of Anticholinesterase Interference with Tau Aggregation Inhibitor Activity in a Tau-Transgenic Mouse Model (Q89855151) (← links)
• Modification of NO-cGMP Pathway Differentially Affects Diazepam- and Flunitrazepam-Induced Spatial and Recognition Memory Impairments in Rodents (Q91624436) (← links)
• Inhibiting Acetylcholinesterase to Activate Pleiotropic Prodrugs with Therapeutic Interest in Alzheimer's Disease (Q92343980) (← links)